Lantern Pharma Inc
(LTRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,511 | 21,938 | 37,743 | 51,524 | 19,229 |
| Marketable Securities | 16,502 | 19,365 | 17,994 | 19,201 | N/A |
| TOTAL | $25,248 | $43,341 | $58,723 | $72,716 | $20,237 |
| Non-Current Assets | |||||
| PPE Net | 47 | 52 | 48 | 30 | 22 |
| Other Non-Current Assets | 277 | 254 | 66 | 1,204 | 101 |
| TOTAL | $324 | $306 | $114 | $1,234 | $123 |
| Total Assets | $25,572 | $43,648 | $58,836 | $73,951 | $20,360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,140 | 2,505 | 2,745 | 2,174 | 552 |
| TOTAL | $4,331 | $2,678 | $2,798 | $2,326 | $552 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 109 |
| Other Non-Current Liabilities | 53 | 62 | 0 | 53 | 0 |
| TOTAL | $53 | $62 | $N/A | $53 | $109 |
| Total Liabilities | $4,384 | $2,740 | $2,798 | $2,379 | $661 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,785 | 10,741 | 10,857 | 10,780 | 11,170 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -76,026 | -55,244 | -39,283 | -25,023 | -12,660 |
| Other shareholders' equity | 154 | -108 | -371 | -93 | 0 |
| TOTAL | $21,188 | $40,908 | $56,038 | $71,571 | $19,699 |
| Total Liabilities And Equity | $25,572 | $43,648 | $58,836 | $73,951 | $20,360 |